223 related articles for article (PubMed ID: 20167841)
1. Trimetazidine, administered at the onset of reperfusion, ameliorates myocardial dysfunction and injury by activation of p38 mitogen-activated protein kinase and Akt signaling.
Khan M; Meduru S; Mostafa M; Khan S; Hideg K; Kuppusamy P
J Pharmacol Exp Ther; 2010 May; 333(2):421-9. PubMed ID: 20167841
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties.
Kutala VK; Khan M; Mandal R; Ganesan LP; Tridandapani S; Kalai T; Hideg K; Kuppusamy P
J Pharmacol Exp Ther; 2006 Jun; 317(3):921-8. PubMed ID: 16467453
[TBL] [Abstract][Full Text] [Related]
3. Trimetazidine protects against myocardial ischemia/reperfusion injury by inhibiting excessive autophagy.
Wu S; Chang G; Gao L; Jiang D; Wang L; Li G; Luo X; Qin S; Guo X; Zhang D
J Mol Med (Berl); 2018 Aug; 96(8):791-806. PubMed ID: 29955901
[TBL] [Abstract][Full Text] [Related]
4. The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway.
Liu Z; Chen JM; Huang H; Kuznicki M; Zheng S; Sun W; Quan N; Wang L; Yang H; Guo HM; Li J; Zhuang J; Zhu P
Metabolism; 2016 Mar; 65(3):122-30. PubMed ID: 26892523
[TBL] [Abstract][Full Text] [Related]
5. Trimetazidine protects isolated rat hearts against ischemia-reperfusion injury in an experimental timing-dependent manner.
Pantos C; Bescond-Jacquet A; Tzeis S; Paizis I; Mourouzis I; Moraitis P; Malliopoulou V; Politi ED; Karageorgiou H; Varonos D; Cokkinos DV
Basic Res Cardiol; 2005 Mar; 100(2):154-60. PubMed ID: 15616764
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotection by HO-4038, a novel verapamil derivative, targeted against ischemia and reperfusion-mediated acute myocardial infarction.
Mohan IK; Khan M; Wisel S; Selvendiran K; Sridhar A; Carnes CA; Bognar B; Kálai T; Hideg K; Kuppusamy P
Am J Physiol Heart Circ Physiol; 2009 Jan; 296(1):H140-51. PubMed ID: 18978191
[TBL] [Abstract][Full Text] [Related]
7. Effects of trimetazidine on the Akt/eNOS signaling pathway and oxidative stress in an in vivo rat model of renal ischemia-reperfusion.
Mahfoudh-Boussaid A; Hadj Ayed Tka K; Zaouali MA; Roselló-Catafau J; Ben Abdennebi H
Ren Fail; 2014 Oct; 36(9):1436-42. PubMed ID: 25246344
[TBL] [Abstract][Full Text] [Related]
8. Trimetazidine Protects Cardiomyocytes Against Hypoxia/Reoxygenation Injury by Promoting AMP-activated Protein Kinase-dependent Autophagic Flux.
Zhong Y; Zhong P; He S; Zhang Y; Tang L; Ling Y; Fu S; Tang Y; Yang P; Luo T; Chen B; Chen A; Wang X
J Cardiovasc Pharmacol; 2017 Jun; 69(6):389-397. PubMed ID: 28581448
[TBL] [Abstract][Full Text] [Related]
9. (S)-1-(alpha-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (CKD712) reduces rat myocardial apoptosis against ischemia and reperfusion injury by activation of phosphatidylinositol 3-kinase/Akt signaling and anti-inflammatory action in vivo.
Jin YC; Lee YS; Kim YM; Seo HG; Lee JH; Kim HJ; Yun-Choi HS; Chang KC
J Pharmacol Exp Ther; 2009 Aug; 330(2):440-8. PubMed ID: 19458286
[TBL] [Abstract][Full Text] [Related]
10. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways.
Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y
Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558
[TBL] [Abstract][Full Text] [Related]
11. Trimetazidine improves recovery during reperfusion in isolated rat hearts after prolonged ischemia.
Ikizler M; Dernek S; Sevin B; Kural T
Anadolu Kardiyol Derg; 2003 Dec; 3(4):303-8. PubMed ID: 14675878
[TBL] [Abstract][Full Text] [Related]
12. Trimetazidine ameliorates myocardial ischemia-reperfusion injury.
He C; Cao S; Tong Z; Wang W; Zhang Y; Guo C
Pak J Pharm Sci; 2018 Jul; 31(4(Special)):1691-1696. PubMed ID: 30203764
[TBL] [Abstract][Full Text] [Related]
13. Trimetazidine affects pyroptosis by targeting GSDMD in myocardial ischemia/reperfusion injury.
Chen X; Lin S; Dai S; Han J; Shan P; Wang W; Huang Z; Ye B; Huang W
Inflamm Res; 2022 Feb; 71(2):227-241. PubMed ID: 34993560
[TBL] [Abstract][Full Text] [Related]
14. Trimetazidine pretreatment inhibits myocardial apoptosis and improves cardiac function in a Swine model of coronary microembolization.
Liu YC; Li L; Su Q; Liu T; Tang ZL
Cardiology; 2015; 130(2):130-6. PubMed ID: 25612843
[TBL] [Abstract][Full Text] [Related]
15. Effects of dexmedetomidine on myocardial ischemia-reperfusion injury through PI3K-Akt-mTOR signaling pathway.
Zhang J; Jiang H; Liu DH; Wang GN
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6736-6743. PubMed ID: 31378917
[TBL] [Abstract][Full Text] [Related]
16. [Anti-apoptotic effect of insulin in myocardial ischemia-reperfusion and its principal signaling pathway].
Gao F; Yan WL; Zhang HF; Shi DW; Mo QZ; Ma XL
Zhonghua Nei Ke Za Zhi; 2003 Mar; 42(3):153-6. PubMed ID: 12816694
[TBL] [Abstract][Full Text] [Related]
17. Urinary trypsin inhibitors afford cardioprotective effects through activation of PI3K-Akt and ERK signal transduction and inhibition of p38 MAPK and JNK.
Kim SJ; Yoo KY; Jeong CW; Kim WM; Lee HK; Bae HB; Kwak SH; Li M; Lee J
Cardiology; 2009; 114(4):264-70. PubMed ID: 19684396
[TBL] [Abstract][Full Text] [Related]
18. 17-Methoxyl-7-Hydroxy-Benzene-Furanchalcone Ameliorates Myocardial Ischemia/Reperfusion Injury in Rat by Inhibiting Apoptosis and Autophagy Via the PI3K-Akt Signal Pathway.
Xuan F; Jian J; Lin X; Huang J; Jiao Y; Huang W; Li J; Shi Z; Huang R
Cardiovasc Toxicol; 2017 Jan; 17(1):79-87. PubMed ID: 26792585
[TBL] [Abstract][Full Text] [Related]
19. Acute hyperglycaemia enhances oxidative stress and aggravates myocardial ischaemia/reperfusion injury: role of thioredoxin-interacting protein.
Su H; Ji L; Xing W; Zhang W; Zhou H; Qian X; Wang X; Gao F; Sun X; Zhang H
J Cell Mol Med; 2013 Jan; 17(1):181-91. PubMed ID: 23305039
[TBL] [Abstract][Full Text] [Related]
20. Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult.
Huang C; Cui Y; Ji L; Zhang W; Li R; Ma L; Xing W; Zhou H; Chen B; Yu J; Zhang H
Pharm Biol; 2013 Apr; 51(4):463-73. PubMed ID: 23336403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
